Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Study Assessing the Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Hypertension Not Controlled by Monotherapy

NCT00562809 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00562809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Study Assessing the Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Hypertension Not Controlled by Monotherapy
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2003
Completion date
August 31, 2004
Enrollment
1,005 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension